Inflamm Tablet is a combination pharmaceutical formulation containing Bromelain (90 mg), Trypsin (48 mg), and Rutoside (100 mg), designed to provide effective anti-inflammatory and anti-edematous action. Bromelain, a proteolytic enzyme derived from pineapple stems, exhibits potent anti-inflammatory properties by modulating the inflammatory response and facilitating the reduction of swelling and pain. Trypsin, another proteolytic enzyme, complements this effect by promoting the breakdown of inflammatory mediators and enhancing tissue repair processes. Rutoside, a bioflavonoid, contributes to vascular protection through its antioxidant activity, strengthening capillary walls and reducing capillary permeability, thereby mitigating edema and bruising. The synergistic combination of these active ingredients makes Inflamm Tablet suitable for managing acute and chronic inflammatory conditions, including post-traumatic swelling, postoperative edema, and inflammatory disorders of the musculoskeletal system. It is indicated as an adjunct therapy to support recovery by accelerating the resolution of inflammation and promoting tissue healing. Inflamm Tablet should be used under medical supervision, with dosage tailored according to the severity of the condition and patient response. Caution is advised in patients with hypersensitivity to any component, and it is contraindicated in individuals with bleeding disorders or those receiving anticoagulant therapy without medical consultation.